Ocean Biomedical Inc (OCEA)
0.9207
-0.07
(-6.99%)
USD |
NASDAQ |
Sep 20, 16:00
0.9207
0.00 (0.00%)
After-Hours: 20:00
Ocean Biomedical Total Assets (Quarterly): 1.031M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.031M |
| June 30, 2023 | 20.92M |
| March 31, 2023 | 24.98M |
| December 31, 2022 | 110.91M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.395M |
| September 30, 2021 | 2.235M |
| March 31, 2021 | 1.731M |
| December 31, 2020 | 0.386M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.386M
Minimum
Dec 2020
110.91M
Maximum
Dec 2022
20.32M
Average
1.983M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 76.26M |
| Shareholders Equity (Quarterly) | -75.22M |